Location History:
- Florauna, ZA (2015)
- Pelindaba, ZA (2019)
- Flaurana, ZA (2020)
Company Filing History:
3 out of 18 
1 out of 3 
1 out of 94 
Years Active: 2015-2025
Title: Innovations and Contributions of Jan Rijn Zeevaart
Introduction
Jan Rijn Zeevaart is a notable inventor based in Flaurana, South Africa. He has made significant contributions to the field of nuclear science, particularly in the production of radioisotopes and radiopharmaceuticals. With a total of four patents to his name, Zeevaart's work has the potential to impact cancer diagnosis and treatment.
Latest Patents
Zeevaart's latest patents include a method for the production of radioisotopes. This method involves obtaining a radioisotope of a target element from a target compound through high-energy photon irradiation, specifically gamma irradiation. The resulting radioisotope is of a different oxidation state than the target element and can be separated from the target compound using physical or chemical methods. Another significant patent is for a radiopharmaceutical conjugate that targets tumor cells. This invention comprises a metabolite bound to a chelating agent capable of containing a radionuclide, which is further linked to an EPR agent. These conjugates aim to improve the biodistribution and pharmacological toxicity of radiopharmaceuticals used in cancer therapy.
Career Highlights
Throughout his career, Jan Rijn Zeevaart has worked with prominent organizations, including the South African Nuclear Energy Corporation Limited and the South African Nuclear Energy Corporation (Soc) Ltd. His expertise in nuclear energy and radiopharmaceuticals has positioned him as a key figure in advancing medical technologies.
Collaborations
Zeevaart has collaborated with notable individuals in his field, including David Randall Jansen and Geert Cornelis Krijger. These partnerships have likely contributed to the development and refinement of his innovative ideas.
Conclusion
Jan Rijn Zeevaart's contributions to the field of nuclear science and his innovative patents in radiopharmaceuticals highlight his importance as an inventor. His work continues to pave the way for advancements in cancer diagnosis and treatment.